Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15.

about

Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15.

Item

http://www.wikidata.org/entity/Q48136110

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Angiogenesis enhanced by treat ...... through the release of GDF15.

@en

Angiogenesis enhanced by treat ...... through the release of GDF15.

@nl

type

Item

label

Angiogenesis enhanced by treat ...... through the release of GDF15.

@en

Angiogenesis enhanced by treat ...... through the release of GDF15.

@nl

prefLabel

Angiogenesis enhanced by treat ...... through the release of GDF15.

@en

Angiogenesis enhanced by treat ...... through the release of GDF15.

@nl

P1476

Angiogenesis enhanced by treat ...... a through the release of GDF15

@en

P2093

Dong-Mei Gao

http://www.w3.org/2001/XMLSchema#string

Gang Dong

http://www.w3.org/2001/XMLSchema#string

Hui Ma

http://www.w3.org/2001/XMLSchema#string

Jie-Feng Cui

http://www.w3.org/2001/XMLSchema#string

Min Ma

http://www.w3.org/2001/XMLSchema#string

Qiong-Dan Zheng

http://www.w3.org/2001/XMLSchema#string

Rong-Rong Yao

http://www.w3.org/2001/XMLSchema#string

Rui Zhang

http://www.w3.org/2001/XMLSchema#string

Sheng-Long Ye

http://www.w3.org/2001/XMLSchema#string

Si-Fan Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC).

Immunomodulation by thalidomide and thalidomide analogues

NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis.

Macrophage inhibitory cytokine-1: possible bridge molecule of inflammation and prostate cancer.

How to define transarterial chemoembolization failure or refractoriness: a European perspective

A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.

Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo.

Targeting HIF-1α and VEGF by lentivirus-mediated RNA interference reduces liver tumor cells migration and invasion under hypoxic conditions.

Cancer Statistics, 2017.

p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms.

P304

820-830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.1330

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rong-Xin Chen

P577

2018-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29383859

http://www.w3.org/2001/XMLSchema#string

P932

5852341

http://www.w3.org/2001/XMLSchema#string